PCBL Q1 FY27 Revenue at ₹2,474 Cr, EBITDA ₹400 Cr, PAT ₹155 Cr
PCBL reported Q1 FY27 consolidated revenue of ₹2,474 Cr (+17% YoY), EBITDA of ₹400 Cr (+23% YoY), and PAT of ₹155 Cr (+65% YoY). The company declared an interim dividend of ₹4.5 per share. Specialty & Solutions revenue reached ₹394 Cr.
Significant year-on-year growth in key financial metrics (Revenue, EBITDA, PAT) and declaration of interim dividend are material events that will likely impact investor sentiment and the company's stock price.
The company reported strong year-on-year growth in revenue, EBITDA, and PAT, along with the declaration of an interim dividend, indicating positive financial performance.
PCBL Chemical Limited has released its Investor Update for Q1 FY27, reporting consolidated revenue from operations of ₹2,474 crore, a significant increase of 17% year-on-year. The company's Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) stood at ₹400 crore, up 23% year-on-year, while Profit After Tax (PAT) was ₹155 crore, marking a substantial 65% year-on-year growth.
The Specialty & Solutions segment, including Aquapharm Chemical, also showed strong performance, with revenue growing by 17% year-on-year to ₹394 crore and EBITDA for Aquapharm Chemical reaching ₹47 crore. The company also declared an interim dividend of ₹4.5 per equity share.
PCBL highlighted operational achievements including domestic Carbon Black sales volumes growing 15% YoY to 1,02,985 tons, and the commissioning of a 20,000 MTPA Specialty Black line in Mundra. The company is also advancing its Nanovace platform with a pilot plant for advanced materials and proprietary technology development.
Looking ahead, PCBL projects global Carbon Black demand to grow at approximately 3% CAGR, with a focus on expanding its specialty chemical portfolio, cost optimization, and backward integration. The company aims to leverage growth engines such as Advanced Battery Materials, Green Chelates, and Polymers.
What to do with a filing like this
PCBL Chemical Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by PCBL Chemical Limited. Read the original for the full detail.